No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs4147830 |
chr1:94544276-94544277 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
2 |
rs201677120 |
chr1:94544291-94544292 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
3 |
rs115959521 |
chr1:94544294-94544295 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
4 |
rs369227849 |
chr1:94544305-94544306 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
5 |
rs200852134 |
chr1:94544325-94544326 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
6 |
rs78893999 |
chr1:94544327-94544328 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
7 |
rs200279466 |
chr1:94544328-94544329 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
8 |
rs200342537 |
chr1:94544331-94544332 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
9 |
rs534935670 |
chr1:94544380-94544381 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
10 |
rs150798623 |
chr1:94544382-94544383 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
11 |
rs568602789 |
chr1:94544431-94544432 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
12 |
rs535595849 |
chr1:94544456-94544457 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
13 |
rs201710193 |
chr1:94544459-94544460 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
14 |
rs373472070 |
chr1:94544520-94544521 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
15 |
rs575582175 |
chr1:94544615-94544616 |
Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
16 |
rs539830767 |
chr1:94544634-94544635 |
Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
17 |
rs549249258 |
chr1:94544659-94544660 |
Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
18 |
rs114393289 |
chr1:94544662-94544663 |
Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
19 |
rs573177216 |
chr1:94544698-94544699 |
Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
20 |
rs540492735 |
chr1:94544733-94544734 |
Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
21 |
rs561748483 |
chr1:94544742-94544743 |
Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
22 |
rs376406190 |
chr1:94544745-94544746 |
Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
23 |
rs71652550 |
chr1:94544800-94544801 |
Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
24 |
rs71652551 |
chr1:94544802-94544803 |
Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
25 |
rs544004082 |
chr1:94544805-94544806 |
Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
26 |
rs199720469 |
chr1:94544806-94544807 |
Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
27 |
rs113931184 |
chr1:94544807-94544808 |
Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
28 |
rs113788038 |
chr1:94544808-94544809 |
Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
29 |
rs200943894 |
chr1:94544812-94544813 |
Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
30 |
rs550959889 |
chr1:94544817-94544818 |
Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
31 |
rs111777623 |
chr1:94544825-94544826 |
Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
32 |
rs374758024 |
chr1:94544867-94544868 |
Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
33 |
rs267598778 |
chr1:94544890-94544891 |
Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
34 |
rs387906387 |
chr1:94544892-94544893 |
Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
35 |
rs61748550 |
chr1:94544895-94544896 |
Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
36 |
rs61751264 |
chr1:94544897-94544898 |
Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
37 |
rs150686179 |
chr1:94544906-94544907 |
Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
38 |
rs559674920 |
chr1:94544916-94544917 |
Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
39 |
rs372657740 |
chr1:94544920-94544921 |
Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
40 |
rs61783978 |
chr1:94544932-94544933 |
Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
41 |
rs561739905 |
chr1:94544944-94544945 |
Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
42 |
rs372704965 |
chr1:94544950-94544951 |
Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
43 |
rs201263774 |
chr1:94544951-94544952 |
Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
44 |
rs376624031 |
chr1:94544962-94544963 |
Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
45 |
rs61748549 |
chr1:94544977-94544978 |
Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
46 |
rs139650730 |
chr1:94544990-94544991 |
Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
47 |
rs188540377 |
chr1:94544994-94544995 |
Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
48 |
rs61753059 |
chr1:94545031-94545032 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
49 |
rs368747791 |
chr1:94545039-94545040 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
50 |
rs192907013 |
chr1:94545092-94545093 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|